摘要
2021年4月,加拿大心血管学会(CCS)和加拿大心力衰竭学会(CHFS)联合发布了《心力衰竭指南更新:定义新的射血分数降低心力衰竭治疗的药理学标准》,为射血分数降低心力衰竭(HFrEF)患者的药理学管理提供了全面建议和实用提示。该指南重点介绍新的药物治疗HFrEF的作用,定义了HFrEF新的药理学治疗标准,包括4类关键治疗药物,作为大多数患者的标准治疗。该文结合指南推荐意见和循证医学证据,解读HFrEF的药物治疗,以期为我国HFrEF治疗提供参考。
In April 2021,the Canadian Cardiovascular Society(CCS)and the Canadian Heart Failure Society(CHFS)released heart failure guidelines update:defining a new pharmacologic standard of care for heart failure with reduced ejection fraction,provided comprehensive recommendations and practical tips for the pharmacologic management of patients with heart failure with reduced ejection fraction(HFrEF).The guidelines focused on the role of novel pharmacologic therapies for HFrEF,defined a new standard of pharmacologic care for HFrEF that incorporates 4 key therapeutic drug classes as standard therapy for most patients.Combined with the recommendations of the guidelines and evidence-based medicine,this article interpreted the drug treatment of HFrEF,in order to provide reference for the treatment of HFrEF in China.
作者
韩丽珠
尹琪楠
边原
黄雪飞
雷洋
唐凌茜
童荣生
HAN Lizhu;YIN Qinan;BIAN Yuan;HUANG Xuefei;LEI Yang;TANG Lingxi;TONG Rongsheng(Department of Pharmacy&Personalized Drug Therapy Key Laboratory of Sichuan Province,Sichuan Provincial People’s Hospital/Affiliated Hospital of University of Electronic Science and Technology of China,Sichuan Academy of Medical Sciences,Chengdu 610072,China)
出处
《医药导报》
CAS
北大核心
2021年第11期1481-1486,共6页
Herald of Medicine
基金
国家重点研发计划(2020YFC2005506)
个体化药物治疗四川省重点实验室开放课题(2021ZD01)
四川省干部保健科研课题(川干研2021-226)
四川省医学会静脉血栓栓塞症防治专项科研课题(2019HR02)。
关键词
心力衰竭
射血分数降低
药物治疗
指南更新
指南解读
Heart failure,reduced ejection fraction
Drug treatment
Guidelines update
Guidelines interpretation
